RxDoctor Payments Data

Stephanie Rogers, APRN

Adult Health · Little Rock, ARNPI 1669079380

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (40.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Sanofi accounts for 67.4% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $3,409 and has fallen 89.8% since, to $349 in 2025. Among adult health clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,301in general payments, 2019–2025

Across 32 payments — averaging $134.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$3K
  • Johnson & Johnson$801
  • Astellas Pharma US Inc$199
  • Sun Pharmaceutical Industries Inc.$108
  • Beigene USA, Inc.$100
  • AstraZeneca$87
  • plus $105 from 3 others

What the payments were for

  • Consulting fees$1,76041%
  • Travel & lodging$85520%
  • Food & beverage$1,28730%
  • Education$3999%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,301 in reported general payments places this provider in the 90th percentile of 154 adult health providers in Arkansas.

See all adult health providers in Arkansas

Medicare billing

Part B allowed, 2024
$6,570
Medicare patients
77
Services billed
100

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RevlimidLenalidomide32$490,529
PomalystPomalidomide13$271,344
Lenalidomide16$173,805
EliquisApixaban19$12,916
Acyclovir225$3,166
Potassium Chloride82$1,104
Dapsone31$856
Dexamethasone46$678
Ventolin HfaAlbuterol Sulfate12$650
Gabapentin53$533
Albuterol Sulfate HfaAlbuterol Sulfate16$520
Pantoprazole Sodium34$312
Levofloxacin13$293
Montelukast Sodium39$177
Folic Acid31$177

Paid to pharmacies, not to this prescriber.

Other adult health in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →